Oct 29, 2024, 15:22
Hope Rugo: Optimizing Therapy for Patients with Breast Cancer Harboring PI3K/AKT/PTEN Pathway Abnormalities
Hope Rugo, Director of Breast Oncology and Clinical Trials Education at the UCSF, shared a post on X:
”Join us! with Research To Practice and Komal Jhaveri: LIVE WEBINAR: October 31, 2024, 5 – 6 PM ET. Optimizing Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer Harboring PI3K/AKT/PTEN Pathway Abnormalities.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Oct 29, 2024, 15:20
Oct 29, 2024, 15:14
Oct 29, 2024, 15:03
Oct 29, 2024, 14:57
Oct 29, 2024, 13:53
Oct 29, 2024, 13:19
Oct 29, 2024, 13:05
Oct 29, 2024, 12:51